Citius Pharmaceuticals, Inc. (CTXR) › Cash & EquivalentsCitius Pharmaceuticals, Inc. (CTXR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $2.5K2011: $61.5K2012: $41.7K2013: $54.4K2014: $1.55M2015: $676.1K2016: $294.4K2017: $3.20M2018: $9.18M2019: $7.89M2020: $13.86M2021: $70.07M2022: $41.71M2023: $26.48M2024: $3.25M2025: $4.25M$4.25M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.25M+30.8%2024$3.25M-87.7%2023$26.48M-36.5%2022$41.71M-40.5%2021$70.07M+405.6%2020$13.86M+75.6%2019$7.89M-14.0%2018$9.18M+186.6%2017$3.20M+988.5%2016$294.4K-56.5%2015$676.1K-56.4%2014$1.55M+2753.6%2013$54.4K+30.6%2012$41.7K-32.2%2011$61.5K+2359.1%2010$2.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share